Related Experiment Videos
Increased caveolin-1 expression in Alzheimer's disease brain
Sophie B Gaudreault1, Doris Dea, Judes Poirier
1Departments of Psychiatry and Neurology & Neurosurgery, Douglas Hospital Research Centre, McGill University, Montreal, Que., Canada H4A 2B4.
Neurobiology of Aging
|May 29, 2004
Summary
Alzheimer's disease (AD) is linked to cholesterol dysregulation. This study found increased caveolin protein and mRNA in AD brains, suggesting a role for cholesterol transport in AD pathophysiology.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Cholesterol is increasingly implicated in Alzheimer's disease (AD) pathology.
- Caveolin, a cholesterol-binding protein, is crucial for cellular cholesterol transport.
Purpose of the Study:
- To investigate changes in hippocampal caveolin protein levels in autopsy-confirmed Alzheimer's disease (AD) cases.
- To explore the relationship between caveolin expression and cholesterol homeostasis in the brain.
Main Methods:
- Quantification of caveolin protein in hippocampal tissue from AD and control subjects.
- Measurement of caveolin mRNA levels in the frontal cortex of AD and control brains.
- Analysis of caveolin protein in mouse models (ApoE-deficient and aged wild-type mice).
Main Results:
- Caveolin protein and mRNA levels were approximately doubled in the hippocampus and frontal cortex, respectively, of AD brains compared to controls.
- Increased caveolin protein was observed in mouse models associated with altered cholesterol distribution.
- These findings suggest a link between caveolin-1 expression and disrupted cholesterol homeostasis in brain cells.
Conclusions:
- Caveolin over-expression in the brain is associated with altered cholesterol distribution.
- These alterations in cholesterol homeostasis may contribute to the pathophysiology of Alzheimer's disease.